Severe lupus nephritis: racial differences in presentation and outcome.
about
Treatment for lupus nephritisLupus Nephritis: A Different Disease in European Patients?Lupus Nephritis in Asia: Clinical Features and ManagementPathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalitiesRisk factors for renal failure in patients with lupus nephritis: data from the spanish registry of glomerulonephritis.Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institutionPredictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.Geographical distribution, a risk factor for the incidence of lupus nephritis in China.Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus PatientsClinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.Recent clinical trials in lupus nephritis.Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United StatesEfficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Novel therapeutic agents in clinical development for systemic lupus erythematosus.Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarringThe outcome of proliferative lupus nephritis with pulse cyclophosphamide therapyA retrospective analysis of clinical presentation of lupus nephritisComparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.Organ damage in high-risk patients with systemic and incomplete lupus syndromesNovel Autoantigens Associated with Lupus Nephritis.Lupus or syphilis? That is the question!Glomerular necrotic lesions and long-term outcomes among patients with proliferative lupus nephritis.Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.A study of racial/ethnic differences in treatment preferences among lupus patientsCharacteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan.The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus NephritisInhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritisRenal biopsy pathology in a cohort of patients from southwest Sydney with clinically diagnosed systemic lupus erythematosus.Successful treatment of class V+IV lupus nephritis with multitarget therapy.Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathyInfluence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyReview: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture?Treatment of proliferative lupus nephritis: a slowly changing landscape.Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.Role of TWEAK in lupus nephritis: a bench-to-bedside review.Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.Overview of lupus nephritis management guidelines and perspective from Asia.
P2860
Q24202572-E9BC3CC3-F64E-4600-BF84-F10349539F6BQ26740483-0E9C1575-9CFE-4824-8DD5-629AA30A01CCQ26740487-024019AE-2E1B-4612-9EB4-85F762179EEEQ28080571-C17CFE10-A42C-468E-9CF7-2E4111F048F5Q30576975-F4D6ADA7-1320-479F-A1D2-1FC1A9C49A46Q30655475-0771BD73-47E1-4F24-A243-1F3DDE0D911DQ33497970-240EE600-E324-4D72-BE20-2A4A628E6954Q33560549-08B5E20A-DE51-4B24-AF38-CB1316799EFFQ33578262-F7B95A85-DD1B-4301-9293-325D12925E0BQ33662822-22788FA8-CC33-409F-8301-2FD88F2475BCQ33862188-7F64B36A-BC07-46ED-8E81-7D3D8CE23AB3Q33924437-651390F2-6BF4-416D-973E-A208428F1921Q33945242-A9CA2C31-0902-4AD2-98AF-8B9D192C774DQ34490782-81C02DFB-7969-41CC-AA5F-D8FD4B3638DAQ34704902-78996925-C57D-4B52-A89C-C2F22C88713DQ35019442-EA2CA440-395E-46E6-8548-73524E3482F0Q35180377-24D72CE1-9363-477A-9A9B-E7AA24EC9A00Q35223839-468DFBA6-ABEA-4FE4-A4B4-0988AC04513AQ35321704-D01C3697-CAF0-46B4-AF21-161BCD3D7941Q35600608-1BFD0DA7-8DE5-4449-9A5B-5587D39CE585Q35670637-71ED85D9-6733-49F2-AA17-E93577F54DB1Q35698785-EA6BAC31-A2CD-47F1-B254-BEB15AA81799Q35854401-2DB2FE37-A101-4F54-ADD4-ADFE3111D115Q36012345-221469C1-64DA-4965-BE93-DB58C370DC92Q36157955-BE8714FA-7831-4C86-A325-D6D3FE4D0AC5Q36162841-8B6E87F8-CD27-4463-9B1A-D67C1114499AQ36286317-52A0D7AF-B7D0-403B-A182-98CC8D2906FFQ36299959-38AAE4F5-F476-44E6-AF86-3174438179F9Q36354235-98C3CF38-1248-46D7-8277-CEDD2D7C6EA4Q36617810-DD0496A7-D58D-4AFC-B950-683030743EFDQ36906037-CED0B9D1-C59A-4422-8488-65979F8C32F5Q37146440-B8882A81-27F1-491F-A15A-9D136353F95BQ37462538-7EDFB503-6FF9-4636-A537-ECCB49CE2258Q37678723-904FE8DA-CF10-4530-BFAF-B15B0426E188Q37754835-3D5C6ECE-8321-4694-B4DA-F8815B0FBD62Q37822658-2E82B475-BEEF-4841-BBAB-6DD3097ED6B3Q37857737-C7BC9C32-8B77-4F92-B68F-8942CC3BBF26Q38021183-1E8BEF94-AA3C-4F79-8320-C12D57B124DDQ38023852-D16257E8-9786-4006-8ABE-96EB7616725DQ38123242-EE86E1E5-9041-4720-8C6D-0469410B9D75
P2860
Severe lupus nephritis: racial differences in presentation and outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Severe lupus nephritis: racial differences in presentation and outcome.
@en
Severe lupus nephritis: racial differences in presentation and outcome.
@nl
type
label
Severe lupus nephritis: racial differences in presentation and outcome.
@en
Severe lupus nephritis: racial differences in presentation and outcome.
@nl
prefLabel
Severe lupus nephritis: racial differences in presentation and outcome.
@en
Severe lupus nephritis: racial differences in presentation and outcome.
@nl
P2093
P356
P1476
Severe lupus nephritis: racial differences in presentation and outcome.
@en
P2093
Edmund J Lewis
Joni Evans
Melvin M Schwartz
Stephen M Korbet
P304
P356
10.1681/ASN.2006090992
P577
2006-12-13T00:00:00Z